Weekly Paclitaxel Administered During a Twin Pregnancy for Recurrent Breast Cancer: Case Report and Review of the Literature.
breast cancer
cancer in pregnancy
chemotherapy in pregnancy
pharmacodynamics in pregnancy
pregnancy
twin pregnancy
Journal
Journal of adolescent and young adult oncology
ISSN: 2156-535X
Titre abrégé: J Adolesc Young Adult Oncol
Pays: United States
ID NLM: 101543508
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
pubmed:
19
2
2022
medline:
15
12
2022
entrez:
18
2
2022
Statut:
ppublish
Résumé
Although cancer treatment during single pregnancy has been standardized, how to manage cancer diagnosed during a multiple gestation is still unclear. Chemotherapy during pregnancy has shown to be safe, however, there are reports of increased risks of fetal complications such as intrauterine growth restriction and preterm birth. Also, how to best adjust this to the pharmacokinetic characteristics of a twin gestation has yet to be fully investigated. We report the case of an IVF twin pregnancy with a diagnosis of breast cancer recurrence shortly after conception, and how the pregnancy was managed to obtain optimal obstetric, maternal/oncological, and fetal outcomes.
Identifiants
pubmed: 35180353
doi: 10.1089/jayao.2021.0181
doi:
Substances chimiques
Paclitaxel
P88XT4IS4D
Types de publication
Review
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM